Session date: 
Friday, March 4, 2016 - 7:30am to 8:30am
Location: 
Zablocki VA Medical Center in Auditorium
5000 W National Avenue
Milwaukee, WI
United States
  • 1.00 AMA PRA Category 1 Credit(s)™
    AMA PRA Category 1 Credit(s)™
  • 1.00 Hours of Participation
    Hours of Participation credit.

Please login or register to take this course.
Program Description: 

This educational activity is designed to incorporate evidence-based pathophysiology, diagnosis, and/or treatment of urologic disorders into clinical practice. Speakers will utilize their personal, institutional and evidence-based experience to address patient health care conditions requiring clinical and surgical treatment.  Speakers will also utilize departmental quality improvement data, M&M data, and patient safety data to improve outcomes of urologic disease and other aspects of urologic  patients’ general health. Evidence-based data regarding the changing aspects/newer approaches to surgical disease will be analyzed, and critical issues related to urology within the broader scope of American health care will be discussed.  There are varying degrees to individuals’ knowledge regarding clinical and urologic treatments.  While individuals may be aware of varied treatment within the urologists’ armamentarium it is beneficial to address the topics from an evidence-based approach.

Accreditation Statement
The Medical College of Wisconsin is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians
 
Designation of Credit Statement
The Medical College of Wisconsin designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity
 
Hours of Participation for Allied Health Professionals
The Medical College of Wisconsin designates this activity for up to 1.0 hours of participation for continuing education for allied health professionals.
 
 
Target audience: 
  • Urology Faculty
  • Residents
  • Allied Healthcare Providers
  • Community Physicians
Learning objectives: 
  1. The participant will understand the clinical diagnosis of Peyronie’s disease.
  2. The participant will understand the American Urological Association’s guideline for the treatment of Peyronie’s disease.
  3. The participant will learn about potential treatments which are being developed for the treatment of Peyronie’s disease.
Faculty & credentials: 

Name:

Role in Meeting:

Nathan Grunewald, MDSpeaker
Ken Jacobsohn, MDPlanning Committee
William See, MDPlanning Committee

All persons in control of content have no relevant financial relationships to disclose with the exception of the following person:

In accordance with the ACCME®  Standards for Commercial Support Number 6, all in control of content disclosed any relevant financial relationships.  These relationships were reviewed via the MCW conflict of interest resolution process and resolved.

CME Coordinator Contact Information

Name: 
Tammy Janik
Phone number: 
+1 (414) 805-0788